While Risper believes body enhancements can make companies choose one influencer over another, she emphasises that it is a ...
Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback